rfhg_46843.1

Basic information about the TSS

---

TSS ID: rfhg_46843.1 TSS ID(Version3): hg_37228.1 hg_37226.1 hg_37227.1 Species: human Chr: chr3		Start: 69084926 End: 69085049 Strand: +
Source datasets	FANTOM5|EPD|DRA000914|ENCODE|PRJDB5282|PRJNA401781 |PRJNA4843412|PRJNA548673|DRA013844|PRJNA615891
Protocol	CAGE|TSS_database|C1CAGE|oligo_capping|NETCAGE |ReCappable-seq|TIF-seq2|RAMPAGE|SLIC_CAGE
TSS cluster detected*	14

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3442585,EH38E2211876)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000273258.4:0 ENST00000484921.1:0 ENST00000478935.1:0 ENST00000470936.1:0 ENST00000485444.1:0 AF115965:0 AF125530:0 AF070523:0 AB097051:0 AF161476:0 AK303148:0 AK301637:0 AK074612:0 BC005143:0 BC107899:0 BC020797:0 AB014765:0 AK312731:0 AK223566:0 AB052638:0 AY102608:0 GeneID: 10550 HGNC/MGI_ID: HGNC:16937 UniProt_ID: A0A024R371 B3KQB4 B4DWQ6 B4DZZ0 C9JQU6 F8WF33 F8WF90 Nearer transcript ids and distances: LF364588:194 MA600165:194 LF207312:-368 MA442889:-368 view more...

Gene_name: ADP ribosylation factor like GTPase 6 interacting protein 5 Gene_symbol: ARL6IP5 Gene_synonyms: DERP11 GTRAP3-18 HSPC127 JWA PRAF3 Yip6b Gene_source: HGNC:16937

TATA-Box annotation

---

Distance to TSS:	50
Nearest PromoterID:	NM_006407
Entrez ID:	10550
Nearest Unigene:	Hs.518060
Nearest Refseq:	NM_006407
Nearest Ensembl:	ENSG00000144746
Gene Name:	ADP ribosylation factor like GTPase 6 interacting protein 5
Gene Alias:	DERP11|GTRAP3-18|HSPC127|JWA|PRAF3|Yip6b|addicsin|hp22|jmx
Gene Type:	protein-coding
CpG%:	0.105691
GC%:	0.620968
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ARL6IP5 p2@ARL6IP5 p3@ARL6IP5 p4@ARL6IP5
Sample		p1@ARL6IP5	p2@ARL6IP5	p3@ARL6IP5	p4@ARL6IP5
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	22.60	2.92	0.78	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	17.20	3.84	1.62	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	27.20	3.47	0.39	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	16.84	2.29	0.42	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	16.87	2.02	1.35	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	17.25	1.16	1.55	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	36.39	3.05	0.87	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	30.76	2.18	0.97	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	25.43	0.64	0.85	0.85
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	9.85	1.16	0.58	1.74
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	12.13	1.21	1.62	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	14.23	1.63	0.81	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	68.35	4.51	0.97	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	78.78	3.16	1.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	59.72	4.39	0.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	62.87	5.78	1.76	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	77.32	4.80	2.40	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	66.23	4.64	2.53	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	69.84	4.80	2.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	57.92	4.66	0.90	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	67.23	3.88	1.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	76.13	5.18	2.59	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	68.89	4.39	1.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	70.13	4.61	1.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	68.88	3.87	2.06	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	57.61	2.22	1.58	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	67.58	1.10	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	76.86	4.24	1.41	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	50.40	5.01	3.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	64.06	6.33	1.27	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	66.36	4.81	1.26	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	50.41	4.88	1.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	55.08	4.22	0.63	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	86.59	7.09	3.79	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	61.71	5.05	0.75	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	54.23	5.56	1.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	53.55	5.52	0.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	63.47	5.24	1.61	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	55.10	5.40	1.89	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	58.09	6.24	2.88	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	59.05	5.41	1.41	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	75.39	8.64	2.05	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	48.29	9.70	2.11	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	55.60	7.87	2.62	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	52.60	7.63	3.61	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	47.23	9.31	3.26	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	51.82	9.60	3.12	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	50.07	7.15	3.58	1.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	40.45	10.29	3.83	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	38.82	12.74	4.04	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	39.35	8.20	2.05	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	40.69	6.89	2.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	405.77	69.96	27.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	44.00	8.52	3.55	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	45.73	8.28	3.65	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	166.11	20.13	10.91	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	67.51	11.02	3.21	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	33.71	5.19	2.27	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	34.69	4.18	0.96	2.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	57.84	5.97	3.77	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	50.06	13.40	3.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	38.69	13.46	4.49	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	59.71	1.59	0.80	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	42.13	7.14	3.06	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	38.99	5.85	1.95	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	44.73	4.26	2.13	2.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	468.75	48.49	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	513.34	78.97	15.79	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	80.44	11.70	5.36	3.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	59.01	7.44	4.96	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	66.61	8.44	6.10	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	81.47	10.27	2.65	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	95.59	11.45	4.64	1.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	86.83	10.40	3.97	1.53
Adipocyte - breast, donor1	11376-118A8	323.10	37.70	22.65	1.11
Adipocyte - breast, donor2	11327-117E4	241.76	67.54	39.46	1.12
Adipocyte - omental, donor1	11473-119C6	283.84	32.44	23.54	0.76
Adipocyte - omental, donor2	11474-119C7	156.97	26.16	23.92	1.49
Adipocyte - omental, donor3	11475-119C8	97.80	11.05	11.72	0.33
Adipocyte - perirenal, donor1	11476-119C9	101.44	12.12	5.10	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	46.18	17.59	8.80	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	137.29	17.61	14.00	1.81
Adipocyte - subcutaneous, donor3	11408-118E4	132.76	12.34	7.47	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	166.63	6.06	4.69	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	65.89	2.57	2.06	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	116.53	9.48	4.74	1.12
Adipocyte differentiation, day04, donor4	13028-139E4	114.04	12.34	5.88	2.35
Adipocyte differentiation, day08, donor1	13020-139D5	260.44	102.87	52.76	0.80
Adipocyte differentiation, day08, donor2	13023-139D8	149.44	21.62	12.59	0.97
Adipocyte differentiation, day08, donor3	13026-139E2	166.89	25.59	8.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	144.67	28.38	23.93	1.67
Adipocyte differentiation, day12, donor1	13021-139D6	166.36	74.44	40.76	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	144.92	42.45	30.89	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	131.55	54.32	35.67	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	111.13	57.85	30.45	1.83
Alveolar Epithelial Cells, donor1	11510-119G7	45.75	12.15	7.51	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	4.66	2.51	0.72	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	7.19	3.59	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	45.70	8.46	5.04	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	10.04	1.67	8.37	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	35.13	9.86	3.70	0.21
Anulus Pulposus Cell, donor1	11248-116E6	457.47	28.72	16.48	0.34
Anulus Pulposus Cell, donor2	11463-119B5	106.78	17.39	11.02	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	95.25	32.80	14.83	1.35
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	97.68	32.13	19.54	2.60
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	62.07	21.40	19.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	101.33	34.08	20.92	1.49
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	118.88	40.47	16.44	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	69.31	17.16	7.92	1.98
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	81.87	28.59	12.67	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	97.57	27.18	16.99	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	87.89	26.13	18.41	1.78
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	97.93	27.49	15.82	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	100.14	37.74	14.51	2.18
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	61.44	22.57	12.54	5.02
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	138.71	44.15	22.07	1.48
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	76.43	28.66	16.38	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	89.72	25.48	14.78	2.11
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	87.33	23.04	19.82	2.68
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	79.92	21.16	15.68	1.32
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	84.46	28.07	15.77	1.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	85.84	32.19	23.41	1.95
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	90.56	22.06	10.45	1.16
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	70.84	25.22	13.21	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	116.83	24.78	31.86	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	81.99	26.07	12.35	1.72
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	75.51	20.97	16.78	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	89.32	28.15	13.59	2.43
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	111.18	28.08	11.76	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	82.37	21.80	10.90	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	95.77	30.21	13.68	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	91.71	25.01	17.32	1.07
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	65.81	22.20	11.36	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	81.17	23.46	19.24	1.88
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	86.82	27.97	10.93	2.25
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	68.49	25.68	8.56	1.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	91.84	32.76	15.79	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	89.72	34.62	16.56	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	87.91	22.57	20.20	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	114.43	34.58	16.27	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	93.47	30.05	17.06	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	80.06	31.13	13.34	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	81.13	29.78	16.40	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	95.68	25.40	14.18	1.69
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	62.35	19.14	13.34	1.45
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	90.69	34.01	25.51	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	84.25	25.77	14.24	1.86
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	83.39	25.48	11.58	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	71.83	31.69	16.90	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	84.69	28.09	14.37	1.72
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	84.23	27.07	11.43	2.41
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	88.21	21.14	13.12	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	88.73	31.03	14.48	2.30
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	66.31	22.95	5.10	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	87.96	30.25	19.58	2.03
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	83.61	28.08	16.52	1.45
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	63.34	24.48	8.87	1.53
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	95.60	39.20	13.86	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	71.84	25.50	11.97	1.55
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	70.19	19.84	12.21	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	69.24	22.16	12.74	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	73.61	21.98	14.30	2.12
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	68.33	25.80	10.90	2.18
Astrocyte - cerebellum, donor1	11500-119F6	48.39	2.09	0.37	0.00
Astrocyte - cerebellum, donor2	11580-120F5	15.06	1.03	0.68	0.00
Astrocyte - cerebellum, donor3	11661-122F5	9.86	0.21	0.42	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	227.28	8.71	3.83	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	121.65	11.00	5.34	0.97
Astrocyte - cerebral cortex, donor3	11392-118C6	111.57	6.26	3.43	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	189.00	76.04	18.12	7.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	180.78	79.93	19.29	7.02
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	178.21	73.06	20.71	6.83
Basophils, donor1	12241-129G9	98.07	14.91	5.49	0.00
Basophils, donor2	12242-129H1	193.03	24.17	3.97	0.72
Basophils, donor3	12243-129H2	108.78	10.29	3.38	0.59
Bronchial Epithelial Cell, donor1	11511-119G8	18.33	7.55	3.02	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	0.91	0.91	2.74	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	16.95	6.28	2.51	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	12.68	7.07	2.29	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	14.51	5.07	2.30	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	51.82	5.22	3.42	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	18.65	0.52	0.62	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	90.37	4.43	2.56	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	174.28	7.67	2.88	2.24
CD133+ stem cells - cord blood derived, pool1	12223-129E9	237.86	20.68	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	95.80	9.58	6.20	0.00
CD14+ Monocytes, donor2	11305-117B9	71.46	6.50	2.23	0.74
CD14+ Monocytes, donor3	11381-118B4	72.89	7.46	1.76	0.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	532.69	25.76	8.77	1.70
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	470.05	23.50	12.51	2.65
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	463.85	26.96	12.82	2.30
CD14+ monocytes - mock treated, donor1	11863-125A9	153.51	50.59	18.50	0.72
CD14+ monocytes - mock treated, donor2	11873-125C1	101.99	36.81	15.39	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	129.34	52.59	21.56	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	85.71	37.16	11.05	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	54.37	27.88	11.59	1.38
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	61.98	29.50	8.93	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	64.42	44.06	11.75	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	60.71	56.62	13.00	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	124.27	100.98	21.33	0.87
CD14+ monocytes - treated with Candida, donor1	11868-125B5	86.63	63.68	18.26	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	92.40	57.03	20.07	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	98.73	44.37	23.30	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	105.31	43.43	18.44	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	82.61	44.50	18.76	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	150.32	92.86	30.40	0.83
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	98.84	93.12	24.71	1.37
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	84.83	78.04	24.43	0.90
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	68.52	58.92	18.33	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	93.88	65.90	23.94	1.34
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	119.85	107.64	27.39	2.09
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	121.20	100.58	34.93	1.68
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	50.89	31.41	7.90	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	33.47	26.42	9.51	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	31.59	31.59	6.14	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	80.91	35.57	9.76	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	86.97	52.41	15.24	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	142.69	81.91	21.55	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	54.87	26.62	6.55	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	62.82	32.45	8.58	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	67.28	35.49	10.90	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	340.90	92.20	33.57	1.09
CD14+CD16+ Monocytes, donor2	11801-124D1	330.55	90.78	35.34	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	329.69	60.44	24.04	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	397.87	28.65	13.39	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	375.31	18.34	9.78	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	410.93	26.09	14.72	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	184.49	167.39	53.08	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	219.13	243.50	84.75	1.10
CD14-CD16+ Monocytes, donor3	11911-125G3	256.66	212.65	78.74	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	406.46	16.26	8.13	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	368.82	18.98	4.07	2.71
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	390.42	15.53	8.28	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	420.57	22.92	11.73	2.67
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	477.64	17.15	9.11	3.22
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	361.50	16.85	6.32	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	397.67	23.53	6.27	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	392.85	17.14	6.59	3.95
CD19+ B Cells, donor1	11544-120B5	49.31	5.75	3.29	0.00
CD19+ B Cells, donor2	11624-122B4	50.05	2.18	1.45	0.73
CD19+ B Cells, donor3	11705-123B4	61.59	3.03	2.52	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	182.23	5.25	3.23	1.21
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	135.03	5.19	2.80	0.40
CD34+ Progenitors, donor1	11545-120B6	84.34	2.01	5.02	0.00
CD34+ Progenitors, donor2	11625-122B5	87.64	12.92	6.74	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	175.85	6.76	3.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	209.47	10.37	2.93	0.68
CD4+ T Cells, donor1	11225-116C1	171.74	13.93	6.07	2.86
CD4+ T Cells, donor2	11306-117C1	92.47	12.25	3.06	5.51
CD4+ T Cells, donor3	11382-118B5	119.25	15.55	5.49	2.13
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	503.58	55.64	19.14	13.53
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	483.78	44.92	18.19	13.25
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	507.37	43.69	16.96	13.51
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	336.13	14.22	4.27	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	403.84	21.07	11.24	3.51
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	375.77	29.67	6.59	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	434.85	124.28	33.82	15.32
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	283.34	65.92	25.25	10.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	275.82	59.65	21.76	14.19
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	349.22	34.07	12.55	7.62
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	505.22	40.53	15.37	8.04
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	526.22	42.24	17.16	8.80
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	514.40	67.04	21.08	5.90
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	312.28	39.27	11.22	4.16
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	289.35	28.73	11.03	5.35
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	404.64	21.75	8.70	2.72
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	452.88	19.83	5.90	2.14
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	285.12	16.14	5.38	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	456.71	72.87	20.95	7.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	376.05	54.37	15.16	7.15
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	353.90	43.50	12.61	5.46
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	362.52	27.81	8.60	7.58
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	443.22	32.93	4.77	5.63
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	573.97	38.35	13.51	6.54
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	671.54	47.51	11.88	7.42
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	523.45	37.85	19.39	8.31
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	568.10	37.69	11.17	5.58
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	616.44	44.03	13.02	7.20
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	622.56	47.12	17.18	8.10
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	662.20	63.14	23.10	7.70
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	734.86	59.09	19.70	8.95
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	663.41	40.16	15.23	18.00
CD8+ T Cells, donor1	11226-116C2	165.01	28.81	5.89	8.84
CD8+ T Cells, donor2	11307-117C2	87.10	17.65	2.25	4.51
CD8+ T Cells, donor3	11383-118B6	105.04	18.43	4.80	5.81
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	36.70	15.83	9.86	1.61
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	26.60	17.73	11.02	0.96
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	41.31	25.99	14.23	3.01
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	67.25	33.62	15.01	2.10
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	31.44	18.96	11.52	4.56
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	39.57	25.92	12.28	1.14
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	28.46	15.86	10.00	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	31.58	15.53	9.48	1.84
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	31.66	14.54	9.15	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	47.70	22.64	16.30	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	43.58	21.79	14.82	1.74
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	49.56	19.98	8.53	0.80
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	30.64	13.13	5.25	1.31
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	33.25	8.65	5.01	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	21.63	8.95	4.48	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	34.94	22.33	12.61	2.52
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	34.81	23.31	11.51	2.30
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	31.11	15.32	9.43	2.36
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	40.88	20.60	10.46	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	23.99	13.84	5.84	1.54
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	25.01	16.35	4.81	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	41.31	12.24	7.27	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	35.86	13.01	5.12	1.58
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	24.96	9.08	0.76	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	31.32	3.21	3.21	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	33.57	4.90	1.40	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	30.05	7.01	1.00	2.00
Cardiac Myocyte, donor1	11525-119I4	45.69	3.66	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	64.23	3.95	2.96	0.00
Cardiac Myocyte, donor3	11686-122I3	110.49	4.74	2.95	0.11
Chondrocyte - de diff, donor1	11261-116G1	151.49	16.29	13.52	0.35
Chondrocyte - de diff, donor2	11338-117F6	156.37	14.93	8.88	0.36
Chondrocyte - de diff, donor3	11410-118E6	157.93	25.15	14.11	1.02
Chondrocyte - re diff, donor2	11339-117F7	359.00	37.60	16.11	0.90
Chondrocyte - re diff, donor3	11411-118E7	135.48	16.18	5.26	2.02
Ciliary Epithelial Cells, donor1	11242-116D9	229.98	17.67	6.77	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	90.85	16.03	5.56	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	94.60	10.71	4.25	0.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	146.26	4.68	1.74	0.55
Corneal Epithelial Cells, donor1	11526-119I5	10.76	2.63	1.54	0.00
Corneal Epithelial Cells, donor2	11606-120I4	13.65	10.24	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	13.55	3.07	1.53	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	232.12	88.33	42.43	0.83
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	253.27	81.38	36.90	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	248.45	148.38	48.31	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	149.35	99.03	41.58	0.65
Dendritic Cells - plasmacytoid, donor1	11228-116C4	202.25	6.49	2.39	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	210.22	8.49	5.88	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	131.63	3.39	1.45	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	91.22	21.35	7.34	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	52.81	12.32	8.80	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	72.11	16.40	6.79	0.57
Endothelial Cells - Aortic, donor3	11412-118E8	52.29	25.56	11.40	0.39
Endothelial Cells - Artery, donor1	11264-116G4	46.54	19.49	7.27	2.33
Endothelial Cells - Artery, donor2	11341-117F9	55.29	18.82	6.12	0.00
Endothelial Cells - Artery, donor3	11413-118E9	66.27	22.97	8.24	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	118.36	15.52	6.21	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	136.92	17.95	12.78	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	112.20	12.40	7.33	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	60.62	27.93	13.07	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	76.54	17.70	19.26	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	36.72	8.65	2.69	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	93.23	26.41	12.00	1.60
Endothelial Cells - Thoracic, donor2	11343-117G2	43.50	23.59	5.77	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	184.88	17.15	7.58	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	51.49	6.30	1.74	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	74.13	10.75	3.42	0.24
Endothelial Cells - Vein, donor1	11267-116G7	37.54	25.03	3.41	0.00
Endothelial Cells - Vein, donor2	11344-117G3	53.09	17.46	4.89	0.70
Endothelial Cells - Vein, donor3	11416-118F3	54.95	17.90	5.02	0.63
Eosinophils, donor1	12244-129H3	152.47	15.25	30.49	0.00
Eosinophils, donor2	12245-129H4	120.47	46.21	29.70	0.00
Eosinophils, donor3	12246-129H5	135.54	46.37	14.27	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	17.84	2.69	1.47	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	48.81	16.27	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	81.69	11.08	5.34	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	79.05	9.96	6.13	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	16.14	1.30	1.08	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	182.65	23.65	10.55	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	125.69	14.47	11.33	0.96
Fibroblast - Aortic Adventitial, donor2	11326-117E3	87.01	5.70	4.01	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	170.74	7.90	9.22	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	110.95	8.30	6.31	0.33
Fibroblast - Cardiac, donor1	11268-116G8	71.67	26.31	8.17	0.00
Fibroblast - Cardiac, donor2	11345-117G4	24.25	8.34	3.03	0.76
Fibroblast - Cardiac, donor3	11417-118F4	47.95	16.09	4.26	0.00
Fibroblast - Cardiac, donor4	11452-119A3	202.48	11.21	9.70	0.30
Fibroblast - Cardiac, donor5	11456-119A7	75.38	14.21	5.08	0.51
Fibroblast - Cardiac, donor6	11460-119B2	75.34	11.37	5.91	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	81.33	11.93	6.83	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	73.34	7.33	6.04	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	74.70	10.25	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	39.44	0.92	2.08	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	342.77	21.88	15.43	0.85
Fibroblast - Dermal, donor1	11269-116G9	91.10	27.70	22.54	1.17
Fibroblast - Dermal, donor2	11346-117G5	86.79	12.74	11.32	0.00
Fibroblast - Dermal, donor3	11418-118F5	126.21	19.58	9.55	0.60
Fibroblast - Dermal, donor4	11450-119A1	76.42	4.18	1.58	0.23
Fibroblast - Dermal, donor5	11454-119A5	65.42	4.01	3.31	0.35
Fibroblast - Dermal, donor6	11458-119A9	83.49	5.85	2.92	0.81
Fibroblast - Gingival, donor1	11237-116D4	273.20	35.40	18.12	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	111.35	11.27	6.03	0.00
Fibroblast - Gingival, donor2	11318-117D4	144.30	11.47	3.95	0.53
Fibroblast - Gingival, donor3	11394-118C8	210.49	21.66	7.93	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	199.47	16.62	6.23	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	70.13	7.58	3.70	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	99.31	6.08	3.74	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	124.68	13.66	7.17	0.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	19.41	4.23	1.06	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	102.22	10.24	5.56	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	107.04	9.41	4.09	0.68
Fibroblast - Gingival, donor8 (control)	11926-125H9	59.89	2.63	1.21	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	150.70	8.80	2.64	0.15
Fibroblast - Lung, donor1	11270-116H1	38.06	4.08	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	195.47	10.45	2.98	0.00
Fibroblast - Lung, donor3	11419-118F6	89.27	11.40	4.22	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	27.49	3.33	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	33.57	4.20	4.20	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	7.84	1.40	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	85.25	10.15	9.74	0.00
Fibroblast - Mammary, donor2	11620-122A9	3.99	3.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	65.52	11.91	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	250.42	14.74	4.85	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	122.71	6.37	3.19	0.15
Fibroblast - Periodontal Ligament, donor3	11395-118C9	288.24	41.00	22.03	1.22
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	81.67	5.34	3.43	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	95.85	13.23	6.75	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	83.73	11.13	3.48	1.28
Fibroblast - Pulmonary Artery, donor1	11250-116E8	152.76	28.41	9.73	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	57.71	5.89	2.44	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	24.72	1.34	2.67	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	105.96	7.51	3.56	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	95.85	8.14	10.32	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	164.65	5.51	4.80	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	150.57	7.69	3.94	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	108.61	7.22	6.02	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	188.48	13.39	8.85	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	59.22	4.56	4.30	0.51
Fibroblast - skin normal, donor1	11553-120C5	180.65	13.95	12.14	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	192.09	10.63	7.22	0.80
Fibroblast - skin normal, donor2	11561-120D4	128.59	11.65	7.33	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	74.35	3.32	1.21	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	189.22	7.46	4.89	0.25
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	336.43	16.92	14.02	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	118.89	12.15	10.51	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	151.69	15.66	9.27	0.53
Fibroblast - skin walker warburg, donor1	11554-120C6	145.74	11.47	5.40	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	168.89	15.37	7.84	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	1107.99	44.32	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	32.25	3.49	0.87	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	98.81	85.12	38.31	4.16
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	103.06	78.07	32.79	1.56
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	80.49	52.89	24.78	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	35.98	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	37.01	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	29.67	2.00	0.57	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	48.53	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	39.27	0.46	0.00	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	31.11	0.79	0.99	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	49.17	0.53	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	36.20	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	19.02	0.44	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	51.87	0.71	1.13	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	56.89	2.09	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	36.00	1.61	1.61	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	83.50	11.65	4.58	1.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	65.89	5.12	3.05	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	42.90	3.25	2.44	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	91.27	8.44	4.79	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	75.61	6.35	3.11	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	48.74	3.72	1.75	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	114.65	7.98	3.55	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	88.06	8.27	2.23	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	67.47	5.14	2.01	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	95.57	14.32	3.23	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	112.81	9.84	2.88	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	136.20	9.84	4.26	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	246.93	27.89	8.74	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	220.64	23.05	9.73	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	111.65	14.05	3.98	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	160.40	11.48	5.74	0.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	147.83	12.05	6.74	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	149.37	15.27	3.92	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	127.98	15.33	5.76	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	101.56	12.17	3.17	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	128.95	18.08	4.85	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	151.28	14.76	5.41	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	86.88	6.48	2.43	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	142.08	10.90	3.85	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	96.74	15.82	4.93	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	95.22	10.60	4.90	1.27
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	144.14	18.85	5.47	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	110.71	20.91	7.42	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	89.58	10.98	2.85	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	118.39	16.27	3.93	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	76.29	23.52	4.81	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	118.73	15.51	4.81	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	87.37	15.76	6.43	0.92
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	82.26	14.77	4.27	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	100.03	7.59	1.36	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	122.59	15.30	3.87	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	121.94	10.75	2.41	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	133.89	5.95	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	115.42	11.08	4.62	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	108.14	11.70	3.83	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	303.98	9.15	3.81	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	54.54	1.19	1.99	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	37.44	1.08	0.77	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	40.10	0.82	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	34.42	0.31	0.63	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	35.04	0.28	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	22.14	0.92	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	32.17	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	45.64	0.00	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	32.09	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	31.30	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	47.19	0.33	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	48.18	0.82	1.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	39.99	0.00	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	50.06	0.84	1.40	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	50.01	1.31	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	40.26	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	60.43	0.00	0.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	60.80	1.36	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	64.73	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	72.73	2.86	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	51.21	0.30	0.59	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	76.24	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	86.98	2.07	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	72.72	1.38	2.30	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	84.30	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	70.73	2.31	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	90.95	1.30	1.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	70.23	2.01	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	125.60	0.39	1.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	60.94	2.05	1.37	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	77.03	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	92.48	1.42	0.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	93.54	2.41	1.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	97.16	1.53	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	98.91	1.20	0.80	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	119.39	1.97	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	83.81	1.18	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	106.19	1.75	0.58	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	104.45	1.32	1.76	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	91.55	0.00	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	105.06	4.18	1.79	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	104.81	0.97	1.94	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	39.95	3.42	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	49.48	8.73	3.74	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	59.60	11.24	7.87	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	217.57	33.94	23.15	1.90
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	178.79	43.86	21.72	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	115.46	15.32	5.80	1.16
Hep-2 cells mock treated, biol_rep2	11899-125E9	110.73	12.49	4.90	1.52
Hep-2 cells mock treated, biol_rep3	11900-125F1	104.88	13.88	5.23	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	109.64	16.40	4.92	0.87
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	102.30	13.32	7.31	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	96.88	10.98	3.01	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	96.27	15.57	5.36	0.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	86.80	15.44	5.32	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	82.98	8.97	4.16	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	27.42	3.36	1.12	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	8.66	2.60	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	50.23	13.22	23.79	5.29
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	31.74	1.76	1.76	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	19.62	0.73	2.18	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	100.36	8.22	4.02	0.17
Hepatocyte, donor1	11523-119I2	20.58	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	31.24	3.23	2.15	0.00
Hepatocyte, donor3	11684-122I1	49.08	4.91	1.23	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	53.52	6.53	1.31	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	145.07	5.59	2.97	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	138.99	35.40	14.82	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	6.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	1.38	0.00	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	7.69	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	8.12	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	3.33	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	3.63	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	5.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	7.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	8.19	1.89	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	1.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	5.81	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	3.22	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	4.07	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	4.62	0.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	11.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	7.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	7.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	5.44	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	8.61	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	2.54	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	2.55	0.00	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	12.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	7.14	0.00	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	9.88	0.62	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	3.51	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	2.78	0.70	1.39	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	2.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	9.59	0.00	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	9.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	9.60	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	2.77	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	5.70	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	2.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	9.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	3.17	0.00	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	65.85	38.60	17.38	1.39
Keratinocyte - epidermal, donor2	11349-117G8	7.61	3.51	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	32.28	3.31	1.14	0.28
Keratinocyte - oral, donor1	11251-116E9	211.60	48.59	11.69	1.36
Keratocytes, donor1	11527-119I6	45.73	0.69	0.34	0.00
Keratocytes, donor2	11607-120I5	22.26	3.52	4.69	0.00
Keratocytes, donor3	11688-122I5	66.20	2.57	1.58	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	93.85	21.57	8.63	0.00
Lens Epithelial Cells, donor2	11609-120I7	262.84	25.95	14.65	0.69
Lens Epithelial Cells, donor3	11690-122I7	115.64	17.86	9.69	0.50
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	85.26	22.17	7.47	0.59
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	44.65	6.70	3.91	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	72.57	19.36	7.24	0.94
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	50.55	10.75	6.45	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	43.49	9.77	3.15	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	51.86	13.91	6.58	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	49.25	12.72	6.57	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	45.00	8.34	3.03	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	52.78	11.68	5.77	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	60.12	15.43	5.14	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	47.89	9.89	4.46	0.78
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	36.10	8.33	4.26	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	57.84	17.07	8.71	1.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	43.89	9.78	5.25	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	42.17	15.11	4.26	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	59.44	19.71	8.31	1.23
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	28.99	4.99	2.18	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	45.56	14.09	4.76	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	59.24	14.48	6.58	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	26.36	6.15	2.05	0.88
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	37.84	9.21	5.73	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	55.77	13.09	5.82	1.94
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	56.28	9.69	2.42	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	55.10	13.47	7.11	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	53.40	12.96	10.89	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	51.93	10.26	5.03	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	48.72	13.98	6.01	0.90
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	46.09	17.88	9.63	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	47.79	10.72	4.52	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	44.32	11.66	4.35	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	47.49	15.02	10.66	1.94
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	39.69	10.59	4.96	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	40.51	11.40	5.20	0.87
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	79.60	21.47	11.48	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	46.20	12.35	4.45	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	36.02	10.31	3.30	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	59.82	16.73	11.26	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	57.82	18.26	7.61	1.52
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	62.56	19.32	8.12	0.84
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	52.98	16.00	7.82	1.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	37.33	4.36	2.91	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	27.39	8.25	2.80	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	53.36	14.68	4.66	1.43
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	33.65	12.09	5.23	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	29.19	10.59	3.77	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	89.60	24.63	8.91	1.61
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	26.12	6.15	3.59	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	39.08	7.76	3.58	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	24.93	4.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	19.95	1.53	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	20.04	3.71	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	15.23	1.27	1.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	18.29	1.41	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	14.01	1.87	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	12.37	0.52	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	7.14	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	24.66	1.36	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	31.70	1.45	2.33	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	28.36	2.25	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	23.98	1.90	0.41	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	20.03	3.59	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	27.88	2.82	1.76	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	29.32	1.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	15.79	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	36.29	1.87	0.80	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	31.74	3.59	0.57	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	18.41	0.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	19.57	4.08	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	26.03	2.08	0.62	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	27.75	2.80	0.28	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	12.36	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	29.32	2.03	0.87	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	26.90	2.69	1.20	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	27.11	1.11	2.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	18.38	1.77	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	19.55	2.58	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	14.97	3.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	19.19	1.54	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	21.51	1.13	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	17.23	0.82	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	14.01	2.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	10.05	2.15	2.15	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	19.42	2.99	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	18.58	1.49	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	23.26	2.15	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	17.98	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	21.66	2.00	1.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	16.29	0.60	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	17.06	1.42	2.13	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	19.25	1.72	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	17.18	2.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	12.12	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	14.45	2.22	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	26.75	3.49	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	15.87	0.00	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	19.21	2.80	0.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	20.35	1.45	1.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	15.33	1.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	16.77	0.99	1.48	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	11.29	2.82	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	15.59	1.01	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	18.02	0.45	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	12.05	6.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	14.70	1.34	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	16.42	1.17	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	13.19	1.98	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	20.24	1.04	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	21.00	0.88	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	20.13	2.24	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	18.99	1.32	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	22.37	1.93	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	24.31	2.03	1.01	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	18.74	1.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	21.87	1.19	0.80	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	15.80	2.43	1.22	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	17.29	0.69	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	24.70	2.28	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	16.53	1.55	0.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	11.49	1.21	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	25.67	1.27	0.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	9.60	0.53	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	13.79	1.15	1.15	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	18.00	1.03	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	16.27	1.41	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	8.51	2.84	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	17.89	1.66	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	10.96	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	11.27	0.42	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	15.33	0.00	0.46	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	12.04	0.67	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	13.37	1.60	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	18.59	1.62	0.40	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	11.93	0.92	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	13.34	0.89	1.78	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	12.54	1.71	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	16.87	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	21.34	1.09	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	18.26	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	29.11	2.34	1.30	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	13.26	0.66	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	27.02	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	291.05	31.68	11.62	0.91
Macrophage - monocyte derived, donor2	11313-117C8	246.08	78.17	45.88	0.55
Macrophage - monocyte derived, donor3	11389-118C3	132.65	49.42	20.71	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	103.55	99.83	44.07	2.66
Mallassez-derived cells, donor2	11929-125I3	178.10	122.80	56.25	4.75
Mallassez-derived cells, donor3	11930-125I4	137.46	101.32	44.61	4.31
Mammary Epithelial Cell, donor1	11273-116H4	94.56	9.37	5.28	0.80
Mammary Epithelial Cell, donor2	11350-117G9	81.94	13.32	4.63	0.00
Mammary Epithelial Cell, donor3	11422-118F9	13.47	3.74	1.75	0.00
Mast cell - stimulated, donor1	11487-119E2	636.58	92.20	26.44	0.68
Mast cell, donor1	11563-120D6	384.98	20.65	8.11	1.30
Mast cell, donor2	11565-120D8	249.63	5.35	2.38	1.19
Mast cell, donor3	11566-120D9	234.80	3.38	1.35	0.23
Mast cell, donor4	11567-120E1	250.86	4.43	1.95	0.89
Mast cell, expanded and stimulated, donor5	11940-126A5	431.04	69.86	32.27	2.77
Mast cell, expanded and stimulated, donor8	11942-126A7	296.51	72.96	45.53	2.92
Mast cell, expanded, donor5	11939-126A4	347.49	19.62	6.31	0.34
Mast cell, expanded, donor8	11941-126A6	340.76	75.65	26.11	3.35
Melanocyte - dark, donor1	11502-119F8	133.82	13.53	6.67	0.50
Melanocyte - dark, donor2	11582-120F7	72.68	6.23	1.38	0.00
Melanocyte - dark, donor3	11663-122F7	162.12	5.65	2.68	0.00
Melanocyte - light, donor1	11274-116H5	52.42	4.23	0.94	0.24
Melanocyte - light, donor2	11351-117H1	50.50	3.41	0.68	0.00
Melanocyte - light, donor3	11423-118G1	31.22	2.60	3.47	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	103.81	8.02	2.39	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	115.91	12.91	6.19	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	135.80	12.86	3.48	0.00
Meningeal Cells, donor1	11493-119E8	87.21	9.18	4.09	0.25
Meningeal Cells, donor2	11573-120E7	50.62	6.16	3.08	0.00
Meningeal Cells, donor3	11654-122E7	194.79	19.80	8.48	0.82
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	237.54	12.83	7.70	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	106.27	5.53	2.42	0.81
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	18.40	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	18.31	2.62	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	63.87	9.33	5.74	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	134.68	11.65	5.93	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	101.53	11.06	7.54	2.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	49.44	3.52	1.54	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	29.22	1.46	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	32.33	2.05	1.23	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	210.67	17.59	10.39	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	23.42	1.86	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	202.62	6.58	3.42	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	30.27	2.37	0.59	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	30.10	4.48	1.92	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	139.65	12.76	8.51	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	172.94	3.75	3.13	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	59.51	2.90	1.45	0.00
Mesothelial Cells, donor1	11247-116E5	177.67	36.86	20.68	3.71
Mesothelial Cells, donor2	12156-128G5	141.63	36.53	25.02	0.50
Mesothelial Cells, donor3	11402-118D7	109.99	16.04	7.37	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	48.61	14.85	8.10	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	129.79	27.34	16.25	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	112.19	34.75	21.50	1.18
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	3.46	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	135.45	13.02	10.85	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	118.03	30.29	20.12	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	23.16	4.63	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	165.67	32.03	16.77	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	95.42	21.41	16.29	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	161.15	27.84	16.66	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	92.66	27.72	17.82	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	161.94	33.63	19.47	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	140.96	39.13	29.26	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	10.53	3.95	5.26	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	158.74	30.77	11.88	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	23.94	12.89	9.21	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	95.68	19.08	11.92	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	6.71	28.50	5.03	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	148.28	28.85	14.80	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	80.57	35.41	20.44	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	18.80	6.63	2.76	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	142.06	37.53	21.87	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	94.02	40.39	23.56	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	74.40	30.37	14.88	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	165.62	32.18	16.73	1.07
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	64.91	36.23	16.45	1.33
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	20.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	87.61	26.50	14.89	1.31
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	40.05	32.45	9.63	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	11.60	1.66	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	59.52	26.91	14.95	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	62.35	45.58	23.23	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	5.45	8.72	4.36	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	88.90	49.98	22.59	1.44
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	78.44	54.03	31.62	2.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	5.48	27.42	4.11	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	76.59	61.07	31.04	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	107.79	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	18.35	50.96	8.15	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	70.07	81.02	41.16	3.07
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	8.83	27.59	7.73	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	8.33	53.79	2.56	1.92
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	85.28	111.56	47.10	2.48
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	16.01	25.75	11.13	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	28.73	88.39	11.05	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	123.76	144.27	55.04	1.37
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	13.57	38.07	9.63	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	7.81	45.10	7.10	1.42
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	116.15	168.33	62.00	2.24
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	24.11	39.48	17.04	1.25
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	11.65	85.08	4.66	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	76.02	150.53	46.46	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	68.03	94.75	40.90	1.25
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	72.19	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	55.41	96.05	36.02	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	53.50	81.38	32.44	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	52.65	120.63	22.52	0.97
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	104.18	154.45	53.64	2.59
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	45.90	120.97	35.18	1.29
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	12.70	78.13	6.99	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	38.17	72.86	22.95	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	109.85	109.26	46.40	1.50
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	56.64	71.62	15.54	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	109.25	166.26	59.56	2.23
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	77.62	113.44	34.94	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	29.58	98.97	13.65	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	116.20	154.55	47.45	2.56
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	102.99	141.09	48.91	2.21
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	21.51	83.41	11.08	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	110.26	97.62	32.05	1.47
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	108.41	143.01	43.25	1.44
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	199.89	107.98	43.28	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	93.21	62.53	25.61	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	207.18	26.37	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	245.95	21.39	10.69	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	266.80	26.61	12.16	1.31
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	212.49	35.77	16.83	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	246.32	25.50	14.63	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	136.90	11.18	4.66	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	205.79	9.01	7.51	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	161.67	25.30	17.84	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	293.84	30.54	17.42	0.79
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	195.23	25.05	10.31	2.21
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	198.60	16.86	9.16	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	199.12	31.11	18.67	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	383.73	41.15	20.84	1.60
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	146.83	38.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	238.35	19.19	12.12	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	180.04	31.20	19.40	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	452.16	47.67	24.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	412.63	35.60	21.62	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	501.29	53.45	18.63	1.62
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	255.26	46.82	27.19	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	85.65	17.13	11.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	264.26	78.30	39.15	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	190.10	57.03	42.77	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	0.00	37.65	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	148.44	58.60	28.87	1.51
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	117.59	21.43	15.16	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	79.43	9.34	6.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	31.72	6.68	2.92	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	88.80	8.75	4.18	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	41.49	15.96	4.79	3.19
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	40.80	1.36	1.36	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	240.73	20.21	11.03	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	62.36	4.60	5.44	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	60.67	9.53	5.35	0.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	69.18	12.70	3.24	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	101.54	20.81	16.61	1.68
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	779.43	55.67	22.27	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	110.19	12.91	11.42	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	86.61	7.85	3.25	1.62
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	70.50	12.92	5.21	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	53.73	6.04	2.45	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	136.33	25.52	13.30	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	90.70	12.20	6.90	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	69.64	6.60	4.20	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	141.12	6.89	4.27	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	53.18	4.23	1.14	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	117.65	16.58	9.00	0.88
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	52.74	9.85	4.92	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	64.36	6.90	2.30	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	68.45	4.82	2.57	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	128.64	9.66	6.55	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	328.70	22.76	17.70	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	64.38	8.91	5.79	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	46.15	4.66	2.96	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	81.41	4.03	2.14	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	74.26	4.29	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	722.22	54.17	36.11	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	51.65	4.67	3.33	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	27.05	3.16	5.41	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	45.63	7.14	4.76	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	68.72	11.14	4.64	2.79
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	79.08	4.54	2.27	1.51
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	32.59	10.10	2.28	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	43.58	4.36	2.18	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	55.18	8.14	4.52	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	39.69	7.94	7.94	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	81.78	3.99	2.66	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	88.79	7.44	2.98	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	32.92	3.45	1.53	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	169.97	5.75	3.63	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	66.75	7.96	5.97	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	48.11	8.13	6.78	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	398.54	15.33	15.33	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	87.18	3.05	2.44	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	29.90	3.78	3.15	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	56.90	1.82	2.12	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	79.91	2.37	2.37	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	111.10	13.60	5.67	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	490.62	20.23	10.12	0.00
Myoblast, donor1	11241-116D8	128.45	56.65	24.72	0.62
Myoblast, donor2	11322-117D8	127.35	36.44	18.41	0.77
Myoblast, donor3	11398-118D3	170.85	27.41	14.29	1.01
NK T cell leukemia cell line:KHYG-1	10777-110G3	96.90	4.23	0.88	0.58
Natural Killer Cells, donor1	11230-116C6	200.81	21.22	5.23	10.15
Natural Killer Cells, donor2	11311-117C6	115.19	13.27	2.41	7.84
Natural Killer Cells, donor3	11387-118C1	127.37	13.07	3.31	6.26
Neural stem cells, donor1	11275-116H6	253.69	15.61	10.16	2.18
Neural stem cells, donor2	11352-117H2	236.85	3.85	9.63	1.93
Neurons, donor1	11494-119E9	97.86	5.69	4.55	0.00
Neurons, donor2	11574-120E8	210.26	5.28	3.74	0.44
Neurons, donor3	11655-122E8	106.06	11.51	2.47	0.00
Neutrophils, donor1	11233-116C9	181.89	62.18	30.62	0.93
Neutrophils, donor2	11314-117C9	179.73	31.89	5.80	0.00
Neutrophils, donor3	11390-118C4	233.34	51.92	37.26	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	417.36	19.00	8.19	0.47
Nucleus Pulposus Cell, donor2	11409-118E5	84.98	7.16	3.26	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	86.24	9.63	5.82	0.00
Olfactory epithelial cells, donor1	11933-125I7	83.14	11.29	4.27	0.14
Olfactory epithelial cells, donor2	11934-125I8	115.51	20.12	7.96	0.58
Olfactory epithelial cells, donor3	11935-125I9	108.28	13.17	8.29	0.45
Olfactory epithelial cells, donor4	11936-126A1	124.77	13.05	6.82	0.97
Oligodendrocyte - precursors, donor1	11496-119F2	169.71	31.90	9.03	3.01
Osteoblast - differentiated, donor1	11276-116H7	108.26	17.23	9.36	0.64
Osteoblast - differentiated, donor2	11353-117H3	61.73	4.57	3.43	2.29
Osteoblast - differentiated, donor3	11425-118G3	66.42	7.45	4.97	0.00
Osteoblast, donor1	11277-116H8	82.47	9.38	4.10	0.39
Osteoblast, donor2	11354-117H4	144.68	9.13	8.43	0.00
Osteoblast, donor3	11426-118G4	60.07	4.62	2.13	0.36
Pancreatic stromal cells, donor1	11249-116E7	231.98	13.73	6.99	0.76
Pericytes, donor1	11491-119E6	15.47	2.23	0.45	0.00
Pericytes, donor2	11571-120E5	12.68	2.26	0.45	0.23
Pericytes, donor3	11652-122E5	28.48	8.75	3.87	0.41
Perineurial Cells, donor1	11499-119F5	196.43	19.33	9.15	0.68
Perineurial Cells, donor2	11579-120F4	153.75	7.18	3.31	0.74
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	306.31	24.22	10.84	1.59
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	103.09	14.45	7.59	1.47
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	106.51	16.31	4.40	2.20
Placental Epithelial Cells, donor1	11278-116H9	9.81	1.43	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	43.25	3.33	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	21.60	1.57	0.39	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	118.99	11.71	7.59	0.32
Preadipocyte - breast, donor1	11467-119B9	171.27	14.07	10.50	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	137.45	12.01	6.66	0.91
Preadipocyte - breast, donor2	11328-117E5	102.67	4.95	3.60	0.45
Preadipocyte - omental, donor1	11468-119C1	216.85	16.52	13.53	0.32
Preadipocyte - omental, donor2	11329-117E6	214.74	17.90	11.35	0.00
Preadipocyte - omental, donor3	11403-118D8	99.13	6.16	5.01	0.43
Preadipocyte - perirenal, donor1	11469-119C2	65.95	7.87	4.92	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	37.78	5.53	2.15	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	100.23	6.02	4.60	0.89
Preadipocyte - subcutaneous, donor3	11428-118G6	104.90	8.51	4.43	0.51
Preadipocyte - visceral, donor1	11280-116I2	210.61	15.56	12.57	1.21
Preadipocyte - visceral, donor2	11357-117H7	117.81	17.95	12.89	0.46
Preadipocyte - visceral, donor3	11429-118G7	88.19	13.27	9.40	0.73
Prostate Epithelial Cells (polarized), donor1	11253-116F2	83.42	1.06	1.06	0.00
Prostate Epithelial Cells, donor2	11331-117E8	59.04	50.51	22.21	2.30
Prostate Epithelial Cells, donor3	11404-118D9	52.24	4.04	2.02	0.24
Prostate Stromal Cells, donor1	11254-116F3	134.17	12.53	4.78	0.23
Prostate Stromal Cells, donor2	11332-117E9	79.97	9.14	5.38	1.26
Prostate Stromal Cells, donor3	11405-118E1	123.57	18.67	7.92	0.63
Renal Cortical Epithelial Cells, donor1	11516-119H4	29.56	6.57	2.19	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	153.53	26.55	10.19	2.50
Renal Epithelial Cells, donor1	11517-119H5	9.64	1.52	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	13.52	4.27	4.98	0.71
Renal Epithelial Cells, donor3	11678-122H4	199.45	41.08	13.23	2.65
Renal Glomerular Endothelial Cells, donor1	11514-119H2	5.45	0.68	2.04	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	25.74	6.33	1.62	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	51.06	10.21	5.11	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	6.65	0.00	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	28.17	4.18	2.42	0.22
Renal Mesangial Cells, donor2	11598-120H5	23.83	2.51	1.25	0.00
Renal Mesangial Cells, donor3	11679-122H5	12.21	1.66	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	55.03	12.62	5.37	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	20.24	4.64	2.53	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	25.65	5.79	1.16	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	160.75	6.22	3.11	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	52.30	5.12	3.41	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	13.38	2.06	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	97.85	2.51	0.50	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	219.56	23.65	6.95	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	26.80	0.89	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	61.64	6.05	2.20	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	42.34	1.74	1.74	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	29.65	1.56	1.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	24.73	2.68	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	50.97	2.34	1.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	54.45	3.10	2.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	34.85	2.45	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	45.30	2.08	0.92	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	17.25	1.10	0.96	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	26.93	2.27	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	35.30	1.61	1.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	23.53	1.15	0.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	29.73	1.93	1.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	33.41	1.77	0.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	14.34	0.76	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	25.15	1.40	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	61.07	3.95	0.75	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	13.27	1.06	1.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	29.10	0.97	0.88	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	32.65	2.10	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	14.84	0.96	0.96	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	23.55	1.40	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	30.42	1.37	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	12.76	0.73	0.73	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	26.86	0.49	0.98	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	27.67	2.82	0.67	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	24.53	0.47	3.07	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	27.38	1.19	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	31.34	1.87	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	20.32	1.45	1.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	29.42	1.33	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	25.48	1.25	0.84	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	17.09	1.75	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	19.07	0.85	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	22.94	1.74	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	28.37	1.89	2.58	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	17.97	1.23	0.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	29.71	1.64	0.66	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	26.59	1.19	1.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	39.95	2.52	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	31.99	1.87	0.80	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	16.32	0.83	1.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	35.72	2.62	0.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	43.53	2.22	1.01	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	27.22	1.70	0.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	34.24	4.54	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	21.15	2.42	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	28.64	2.20	1.47	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	45.41	1.46	0.73	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	34.07	3.04	1.83	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	25.92	1.81	3.62	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	44.33	4.98	1.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	43.73	3.29	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	44.28	2.95	1.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	41.62	2.35	0.64	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	30.05	3.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	11.66	0.56	0.56	0.19
Schwann Cells, donor2	11578-120F3	61.24	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	78.21	4.16	3.07	1.10
Sebocyte, donor1	11220-116B5	77.24	28.48	15.89	0.00
Sebocyte, donor2	11301-117B5	25.74	21.60	7.35	1.38
Sebocyte, donor3	11378-118B1	53.80	7.01	2.68	0.00
Sertoli Cells, donor1	11255-116F4	170.63	6.63	4.97	0.00
Sertoli Cells, donor2	11333-117F1	81.91	5.65	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	115.87	5.28	3.26	0.53
Skeletal Muscle Cells, donor2	11358-117H8	23.13	5.78	2.17	0.00
Skeletal Muscle Cells, donor3	11430-118G8	40.13	2.51	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	104.15	8.95	6.76	0.00
Skeletal Muscle Cells, donor5	11455-119A6	90.97	9.07	5.20	0.30
Skeletal Muscle Cells, donor6	11459-119B1	76.34	5.85	3.08	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	259.70	8.44	6.17	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	149.82	3.71	1.71	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	99.41	6.85	3.67	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	139.86	16.77	8.00	0.67
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	39.08	3.62	1.45	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	50.50	15.27	7.02	0.28
Skin - palm, donor1	10286-104F7	24.17	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	22.49	9.51	3.89	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	21.27	9.00	7.36	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	20.64	8.57	3.89	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	107.59	51.15	20.30	1.81
Small Airway Epithelial Cells, donor2	11334-117F2	39.67	17.02	5.77	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	57.51	15.86	7.82	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	37.03	11.62	3.52	0.82
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	11.11	1.54	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	146.29	10.00	14.01	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	81.12	12.34	1.76	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	67.62	15.69	7.96	1.33
Smooth Muscle Cells - Aortic, donor2	11360-117I1	77.97	15.75	9.84	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	82.66	8.50	6.95	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	126.10	2.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	110.99	30.61	15.97	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	123.02	16.85	8.87	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	74.64	19.84	8.96	1.02
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	162.80	14.00	6.84	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	207.91	27.17	15.36	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	79.15	24.49	11.67	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	26.35	3.90	3.09	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	85.24	8.52	4.57	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	109.11	9.09	6.06	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	12.24	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	41.96	7.63	2.86	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	139.95	10.03	4.72	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	78.56	5.60	2.37	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	78.19	5.56	1.47	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	77.96	21.35	11.45	0.93
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	67.91	16.17	8.62	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	39.15	11.95	5.08	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	18.44	2.39	0.68	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	263.62	13.11	6.20	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	147.04	15.60	8.15	0.70
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	66.67	18.89	9.78	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	38.64	3.02	6.64	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	183.33	10.07	5.83	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	103.86	8.39	5.99	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	84.52	8.39	3.63	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	178.32	8.88	4.31	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	176.56	29.55	19.60	1.66
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	89.27	11.25	3.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	11.63	7.75	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	80.46	6.98	1.86	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	72.70	20.70	10.60	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	60.49	21.94	11.28	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	41.00	5.90	4.13	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	185.36	10.16	5.66	0.42
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	173.32	7.94	9.81	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	75.84	15.54	7.34	0.72
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	73.68	13.51	7.90	1.02
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	38.36	8.09	3.01	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	183.90	6.15	4.89	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	166.82	10.64	5.61	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	6.19	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	83.19	17.13	6.85	0.98
Smooth Muscle Cells - Uterine, donor1	11258-116F7	106.28	11.27	8.40	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	142.49	4.68	4.68	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	118.95	4.28	3.89	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	111.33	11.37	10.31	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	319.50	22.32	18.97	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	220.63	33.42	29.82	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	94.82	19.31	17.03	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	114.62	9.85	4.33	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	163.54	9.40	4.32	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	107.02	3.19	3.19	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	133.34	6.27	5.02	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	189.30	11.46	6.88	0.92
Synoviocyte, donor1	11291-117A4	141.56	11.78	5.89	0.50
Synoviocyte, donor2	11368-117I9	285.97	80.79	44.76	4.86
Synoviocyte, donor3	11440-118H9	158.40	21.67	11.39	3.13
Trabecular Meshwork Cells, donor1	11532-120A2	36.81	1.43	1.79	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	11.89	0.00	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	20.38	0.46	0.46	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	63.51	7.67	5.23	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	31.70	8.89	3.87	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	15.46	7.44	4.01	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	236.08	29.03	10.21	0.49
Urethra, donor2	10319-105A4	26.98	1.80	1.80	0.00
Urothelial Cells, donor1	11520-119H8	19.39	10.89	5.31	1.33
Urothelial Cells, donor2	11600-120H7	12.02	4.81	5.21	0.00
Urothelial Cells, donor3	11681-122H7	8.02	4.81	1.15	0.00
Urothelial cells, donor0	11216-116B1	147.56	38.78	13.82	2.23
Whole blood (ribopure), donor090309, donation1	12179-129A1	429.77	45.38	29.36	3.56
Whole blood (ribopure), donor090309, donation2	12180-129A2	386.00	38.60	32.88	10.01
Whole blood (ribopure), donor090309, donation3	12181-129A3	239.58	35.60	17.80	7.53
Whole blood (ribopure), donor090325, donation1	12176-128I7	392.20	36.16	19.63	2.41
Whole blood (ribopure), donor090325, donation2	12177-128I8	363.14	24.40	20.92	2.32
Whole blood (ribopure), donor090612, donation1	12182-129A4	295.71	44.77	36.44	3.12
Whole blood (ribopure), donor090612, donation2	12183-129A5	381.80	53.23	36.71	4.59
Whole blood (ribopure), donor090612, donation3	12184-129A6	242.83	31.04	17.35	4.56
Wilms' tumor cell line:G-401	10809-111A8	56.01	1.97	0.12	0.00
Wilms' tumor cell line:HFWT	10597-108E3	7.92	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	22.07	4.47	1.40	0.00
achilles tendon, donor2	10292-104G4	28.93	12.40	6.20	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	128.75	3.06	1.27	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	87.53	2.55	0.46	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	57.57	4.51	1.19	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	164.36	16.87	4.63	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	138.01	12.93	3.94	1.41
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	304.11	48.01	12.90	5.92
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	50.36	5.44	2.99	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	111.48	6.17	4.41	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	278.50	20.01	8.98	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	98.63	22.91	4.66	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	53.73	1.47	0.92	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	89.71	11.70	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	78.08	6.97	4.18	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	160.26	15.28	9.58	1.55
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	106.38	9.64	5.55	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	84.59	9.30	1.39	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	86.77	1.65	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	11.05	3.38	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	77.66	11.09	1.71	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	94.32	10.31	3.94	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	112.17	6.74	4.33	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	81.52	6.24	1.56	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	18.68	3.00	3.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	33.45	0.00	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	99.06	18.08	6.03	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	75.01	7.85	1.31	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	26.24	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	83.84	11.07	2.83	0.47
adipose tissue, adult, pool1	10010-101C1	211.74	10.39	6.05	0.00
adipose, donor1	10184-103D4	146.60	1.17	1.17	0.00
adipose, donor2	10185-103D5	41.77	0.81	0.00	0.00
adipose, donor3	10186-103D6	61.81	0.82	0.00	0.27
adipose, donor4	10187-103D7	32.94	2.60	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	23.36	1.58	0.00	0.16
adrenal gland, adult, pool1	10081-102A9	69.12	10.91	10.91	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	253.61	91.78	15.61	3.60
alveolar cell carcinoma cell line:SW 1573	10708-109H6	34.30	1.43	1.07	0.00
amniotic membrane cells, donor1	12235-129G3	209.59	23.42	4.17	0.46
amniotic membrane cells, donor2	12236-129G4	118.00	8.11	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	135.52	4.71	4.12	0.29
amygdala - adult, donor10196	10167-103B5	244.27	8.30	4.74	2.37
amygdala, adult, donor10252	10151-102I7	187.36	3.85	1.01	0.00
amygdala, newborn, donor10223	10360-105E9	61.65	1.94	2.90	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	118.03	2.29	1.02	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	60.01	19.19	1.32	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	53.78	1.34	0.33	0.00
aorta, adult, pool1	10052-101G7	186.13	5.30	1.37	0.59
appendix, adult	10189-103D9	90.43	13.20	3.49	2.33
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	106.62	2.06	2.06	0.00
artery, adult	10190-103E1	199.73	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	207.59	8.26	4.93	0.87
b cell line:RPMI1788	10427-106D4	149.30	23.94	4.31	3.12
basal cell carcinoma cell line:TE 354.T	10702-109G9	192.55	25.53	8.60	1.11
bile duct carcinoma cell line:HuCCT1	10432-106D9	48.43	7.24	1.79	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	103.11	10.54	3.35	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	58.16	5.59	1.68	0.00
bladder, adult, pool1	10011-101C2	218.37	3.69	1.63	0.33
blood, adult, pool1	10053-101G8	192.67	28.79	6.64	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	206.38	53.09	28.26	1.71
bone marrow, adult	10192-103E3	151.16	31.04	6.75	2.02
brain, adult, donor1	10084-102B3	132.23	2.05	3.08	0.00
brain, adult, pool1	10012-101C3	325.17	2.67	1.89	0.45
brain, fetal, pool1	10085-102B4	58.77	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	23.13	6.61	0.99	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	200.84	6.74	3.50	0.00
breast, adult, donor1	10080-102A8	101.02	5.68	3.79	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	62.12	5.21	3.43	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	77.00	4.95	1.86	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	230.91	64.46	13.81	4.14
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	28.08	1.45	0.73	0.00
carcinoid cell line:NCI-H1770	10703-109H1	17.40	3.29	0.47	0.47
carcinoid cell line:NCI-H727	10735-110B6	26.36	1.09	0.33	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	54.19	1.27	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	60.95	2.66	1.33	0.53
caudate nucleus - adult, donor10196	10177-103C6	224.51	5.76	3.45	0.00
caudate nucleus, adult, donor10252	10164-103B2	185.23	2.84	2.01	0.50
caudate nucleus, adult, donor10258	10379-105H1	167.35	4.58	2.29	0.00
caudate nucleus, newborn, donor10223	10354-105E3	82.40	2.56	0.73	0.00
cerebellum - adult, donor10196	10173-103C2	206.84	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	241.69	0.85	1.49	0.00
cerebellum, adult, pool1	10083-102B2	109.00	0.34	0.69	0.34
cerebellum, newborn, donor10223	10357-105E6	67.25	0.83	0.00	0.83
cerebral meninges, adult	10188-103D8	135.65	2.27	1.51	0.00
cerebrospinal fluid, donor2	10294-104G6	29.24	2.19	2.19	0.00
cervical cancer cell line:D98-AH2	10552-107I3	120.63	2.01	0.86	0.14
cervical cancer cell line:ME-180	10553-107I4	89.49	12.43	4.47	0.83
cervix, adult, pool1	10013-101C4	234.55	5.04	3.04	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	91.13	5.71	0.84	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	16.98	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	143.79	36.29	8.82	0.12
choriocarcinoma cell line:SCH	10785-110H2	18.24	0.00	0.00	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	20.40	0.71	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	170.67	38.46	10.54	1.14
chorionic membrane cells, donor2	12239-129G7	157.00	39.77	10.24	0.80
chorionic membrane cells, donor3	12240-129G8	199.46	61.54	15.39	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	61.60	8.08	4.04	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	121.21	14.41	6.92	1.34
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	49.21	1.27	1.06	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	17.21	0.00	0.51	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	10.16	0.24	0.48	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	18.53	0.41	1.02	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	30.92	0.88	1.18	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	102.69	7.82	3.13	1.04
clear cell carcinoma cell line:JHOC-5	10638-108I8	63.32	10.97	2.29	0.23
clear cell carcinoma cell line:TEN	10636-108I6	68.19	8.15	1.91	0.69
colon carcinoma cell line:CACO-2	10513-107D9	101.59	1.83	1.83	0.00
colon carcinoma cell line:COLO-320	10420-106C6	167.62	1.14	0.00	0.00
colon, adult, donor1	10082-102B1	36.89	9.52	1.19	0.00
colon, adult, pool1	10014-101C5	131.49	4.23	2.70	0.00
colon, fetal, donor1	10070-101I7	82.19	8.65	1.24	0.00
common myeloid progenitor CMP, donor1	12130-128D6	4.58	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	74.79	18.70	3.82	4.67
cord blood derived cell line:COBL-a 24h infection	10453-106G3	124.97	30.79	11.02	2.11
cord blood derived cell line:COBL-a untreated	10449-106F8	148.48	50.34	17.91	3.38
corpus callosum, adult, pool1	10042-101F6	295.75	2.10	1.55	0.22
cruciate ligament, donor2	10295-104G7	51.87	8.92	0.81	1.62
diaphragm, fetal, donor1	10069-101I6	98.72	3.21	0.80	0.00
diencephalon, adult	10193-103E4	196.79	3.84	3.60	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	48.22	2.30	0.23	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	118.99	16.67	5.64	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	68.37	4.81	1.69	0.72
ductus deferens, adult	10196-103E7	92.69	0.50	1.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	87.85	1.44	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	93.43	6.62	2.94	0.74
dura mater, adult, donor1	10041-101F5	320.60	11.31	4.87	0.58
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	24.65	0.44	0.22	1.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	88.70	3.30	1.15	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	29.60	13.57	2.47	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	66.60	8.48	0.61	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	42.92	6.79	1.23	0.00
embryonic pancreas cell line:2C6	10603-108E9	22.33	2.63	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	143.13	10.73	3.35	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	262.07	21.75	10.51	1.63
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	53.87	14.47	3.54	0.00
epidermoid carcinoma cell line:A431	10426-106D3	37.79	9.12	2.00	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	78.09	9.02	2.42	0.77
epididymis, adult	10197-103E8	133.96	3.77	1.88	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	87.29	8.69	3.73	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	14.94	1.57	0.79	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	87.28	12.19	3.54	1.05
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	83.56	8.96	3.05	0.20
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	73.38	12.88	4.37	0.45
esophagus, adult, pool1	10015-101C6	171.48	6.90	2.87	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	56.86	0.00	0.25	0.00
eye - muscle inferior rectus, donor1	10272-104E2	33.80	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	61.02	6.31	2.10	0.00
eye - muscle medial, donor2	10299-104H2	22.32	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	34.39	3.44	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	34.98	7.29	1.46	0.00
eye, fetal, donor1	10054-101G9	226.78	5.08	2.80	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	52.19	7.18	1.28	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	55.56	11.87	2.37	0.71
frontal lobe, adult, pool1	10040-101F4	392.84	5.25	5.07	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	29.12	2.40	0.30	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	163.31	26.06	4.57	1.01
gall bladder, adult	10198-103E9	118.54	5.55	1.45	0.24
gamma delta positive T cells, donor1	11937-126A2	434.32	24.70	9.13	5.91
gamma delta positive T cells, donor2	11938-126A3	389.55	38.10	20.54	13.82
gastric adenocarcinoma cell line:MKN1	10614-108G2	79.84	14.57	4.44	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	76.79	3.09	1.74	0.19
gastric cancer cell line:AZ521	10549-107H9	67.71	1.15	0.82	0.00
gastric cancer cell line:GSS	10560-108A2	6.41	0.00	1.83	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	91.38	1.37	2.06	0.23
giant cell carcinoma cell line:LU65	10487-107B1	60.93	8.49	2.87	1.15
giant cell carcinoma cell line:Lu99B	10433-106E1	179.85	12.04	1.68	0.70
glassy cell carcinoma cell line:HOKUG	10688-109F4	53.38	7.48	2.24	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	92.15	10.03	6.65	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	86.51	9.83	3.65	0.42
glioblastoma cell line:T98G	10485-107A8	89.62	4.30	1.77	0.11
glioma cell line:GI-1	10413-106B8	98.11	6.15	0.59	0.29
globus pallidus - adult, donor10196	10175-103C4	125.37	2.92	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	282.42	5.61	2.69	0.49
globus pallidus, adult, donor10258	10367-105F7	179.37	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	62.35	2.13	2.13	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	17.13	7.34	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	76.50	0.00	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	88.85	10.45	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	80.96	10.56	2.56	0.32
hIPS +CCl2, biol_rep1	14383-156B9	43.62	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	46.64	0.46	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	28.98	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	21.56	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	28.12	0.69	1.37	0.00
hIPS, biol_rep3	14382-156B8	126.90	3.31	2.21	1.10
hairy cell leukemia cell line:Mo	10712-109I1	93.39	49.71	13.51	5.75
heart - mitral valve, adult	10205-103F7	148.29	1.20	2.09	0.00
heart - pulmonic valve, adult	10206-103F8	213.36	2.61	2.09	0.00
heart - tricuspid valve, adult	10207-103F9	24.98	2.50	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	82.23	8.16	2.86	0.00
heart, adult, diseased, donor1	10051-101G6	136.27	2.55	2.13	0.00
heart, adult, pool1	10016-101C7	150.64	3.22	1.84	0.23
heart, fetal, pool1	10046-101G1	326.21	5.03	3.08	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	66.95	1.23	0.93	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	1.19	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	47.62	0.55	0.33	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	62.39	1.34	0.61	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	63.76	0.71	0.30	0.00
hepatoma cell line:Li-7	10484-107A7	73.85	2.22	2.00	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	116.08	17.39	3.72	1.01
hippocampus - adult, donor10196	10169-103B7	139.11	1.89	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	212.47	3.06	2.25	0.00
hippocampus, adult, donor10258	10374-105G5	153.37	1.49	3.49	0.50
hippocampus, newborn, donor10223	10363-105F3	43.71	1.41	0.70	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	33.57	1.83	1.22	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	27.10	0.98	0.79	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	24.88	0.25	1.02	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	45.67	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	53.45	0.77	0.26	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	77.44	0.00	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	50.22	0.00	0.58	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	57.52	0.43	0.22	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	45.88	1.25	0.83	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	106.56	2.60	1.66	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	78.11	2.25	0.96	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	107.06	2.69	2.69	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	27.54	0.94	0.78	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	36.85	1.97	0.98	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	61.09	0.00	3.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	82.09	0.19	0.76	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	62.36	0.44	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	71.47	0.00	2.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	87.41	0.19	0.38	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	85.49	0.45	0.45	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	70.48	0.63	0.63	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	140.77	1.80	0.82	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	134.41	1.74	1.16	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	107.91	1.20	0.60	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	41.38	1.11	1.29	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	42.79	1.14	2.57	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	53.49	1.63	0.41	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	86.96	2.11	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	64.93	0.95	0.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	75.05	1.51	0.91	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	70.85	0.52	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	86.34	0.00	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	61.57	0.77	0.77	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	115.55	9.20	3.32	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	90.11	3.03	1.51	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	84.35	3.70	3.70	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	45.16	0.00	0.72	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	49.91	1.34	0.89	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	34.63	0.00	0.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	70.90	1.22	0.92	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	556.30	6.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	96.30	0.33	1.32	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	72.24	0.55	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	64.78	0.36	0.72	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	59.79	0.36	0.71	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	77.57	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	136.64	1.49	1.76	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	63.04	1.62	1.62	0.27
immature langerhans cells, donor1	11904-125F5	248.20	84.99	24.46	2.91
immature langerhans cells, donor2	11905-125F6	83.97	26.14	4.75	1.58
insula, adult, pool1	10039-101F3	303.77	7.10	4.54	0.47
keratoacanthoma cell line:HKA-1	10791-110H8	26.01	14.63	3.90	0.00
kidney, adult, pool1	10017-101C8	202.16	17.72	7.11	0.70
kidney, fetal, pool1	10045-101F9	68.97	2.90	1.56	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	219.85	102.97	27.27	3.69
large cell lung carcinoma cell line:NCI-H460	10839-111E2	60.41	4.70	1.24	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	54.13	3.12	0.55	0.00
left atrium, adult, donor1	10079-102A7	168.36	1.09	2.18	0.00
left ventricle, adult, donor1	10078-102A6	146.13	4.05	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	45.15	1.64	0.27	0.00
leiomyoma cell line:10964C	10569-108B2	164.54	20.84	17.24	0.00
leiomyoma cell line:15242A	10570-108B3	145.65	26.63	25.54	0.00
leiomyoma cell line:15425	10571-108B4	177.74	27.20	18.45	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	146.04	31.75	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	26.14	5.23	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	66.23	6.02	1.53	0.35
liposarcoma cell line:KMLS-1	10782-110G8	107.47	17.96	6.87	0.47
liposarcoma cell line:SW 872	10726-110A6	80.05	4.87	2.07	0.37
liver, adult, pool1	10018-101C9	75.68	4.21	3.24	0.16
liver, fetal, pool1	10086-102B5	17.87	2.82	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	92.45	3.94	1.02	0.00
locus coeruleus, adult, donor10252	10165-103B3	217.95	7.38	2.77	0.00
locus coeruleus, adult, donor10258	10375-105G6	171.26	5.08	1.41	0.28
locus coeruleus, newborn, donor10223	10362-105F2	116.93	7.99	6.31	0.42
lung adenocarcinoma cell line:A549	10499-107C4	65.05	4.43	1.25	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	67.56	16.55	1.38	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	137.22	16.48	4.35	0.79
lung, adult, pool1	10019-101D1	201.76	12.40	5.08	1.06
lung, fetal, donor1	10068-101I5	174.10	4.57	4.28	1.43
lung, right lower lobe, adult, donor1	10075-102A3	84.77	5.50	2.75	0.92
lymph node, adult, donor1	10077-102A5	123.07	11.83	3.79	2.84
lymphangiectasia cell line:DS-1	10727-110A7	138.52	43.62	12.27	7.23
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	59.62	3.02	0.91	0.60
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	84.95	12.74	4.25	0.85
mature adipocyte, donor1	12231-129F8	263.29	22.20	7.10	0.89
mature adipocyte, donor2	12232-129F9	293.44	24.90	11.41	0.83
mature adipocyte, donor3	12233-129G1	398.03	35.09	19.20	0.95
mature adipocyte, donor4	12234-129G2	395.88	36.85	12.63	1.05
maxillary sinus tumor cell line:HSQ-89	10414-106B9	47.65	1.67	1.19	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	301.18	7.90	5.64	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	220.32	4.97	1.84	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	173.14	1.91	2.54	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	223.48	3.41	2.99	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	292.28	7.26	3.71	0.51
medial temporal gyrus, adult, donor10252	10156-103A3	204.37	3.40	2.12	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	119.43	0.00	3.85	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	1708.08	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	81.48	3.23	2.15	0.00
medulla oblongata - adult, donor10196	10174-103C3	145.37	1.30	0.65	0.65
medulla oblongata, adult, donor10252	10155-103A2	246.45	6.81	4.33	0.62
medulla oblongata, adult, pool1	10038-101F2	241.62	5.96	3.02	0.33
medulla oblongata, newborn, donor10223	10361-105F1	114.92	4.86	2.43	0.35
medulloblastoma cell line:D283 Med	10838-111E1	138.60	1.33	1.33	0.00
medulloblastoma cell line:ONS-76	10759-110E3	38.15	3.18	1.35	0.37
melanoma cell line:COLO 679	10514-107E1	94.44	3.31	1.72	0.00
melanoma cell line:G-361	10465-106H6	131.39	3.80	3.26	0.00
meningioma cell line:HKBMM	10691-109F7	83.58	13.57	4.16	1.45
merkel cell carcinoma cell line:MKL-1	10843-111E6	76.66	3.52	1.76	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	59.88	1.30	1.30	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	94.98	9.05	8.13	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	78.17	2.54	2.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	105.18	11.18	11.18	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	211.13	17.56	13.63	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	168.30	32.74	14.44	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	248.48	68.71	43.03	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	152.41	24.89	16.99	1.20
mesenchymal precursor cell - cardiac, donor2	11753-123G7	117.55	13.57	8.97	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	91.25	8.62	3.98	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	118.16	19.18	9.99	1.76
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	87.92	13.94	9.10	1.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	77.40	18.11	12.84	1.65
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	63.10	7.20	3.87	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	170.70	15.71	8.38	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	128.22	10.62	7.55	0.82
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	71.89	11.50	4.31	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	109.66	7.45	3.83	0.62
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	118.78	39.67	21.20	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	197.61	25.17	16.78	2.10
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	42.29	3.29	2.39	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	95.15	19.96	9.89	0.44
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	134.75	5.15	2.58	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	95.00	14.31	7.15	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	136.83	21.05	3.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	112.80	14.61	10.96	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	165.75	21.74	16.63	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	161.77	26.18	15.97	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	159.59	22.80	16.02	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	191.11	25.89	17.89	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	152.31	23.35	15.91	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	155.62	26.72	18.47	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	152.92	30.12	22.71	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	96.61	48.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	206.51	28.55	19.61	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	176.47	25.43	18.96	0.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	172.81	24.52	19.95	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	170.13	33.73	18.33	2.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	153.40	28.87	19.47	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	163.75	20.88	19.24	2.05
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	159.37	26.63	21.91	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	128.52	21.88	13.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	149.78	20.66	15.49	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	141.61	29.56	13.97	1.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	164.41	14.55	8.73	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	156.73	22.39	14.39	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	123.48	18.81	13.90	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	118.17	18.66	9.72	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	123.82	25.18	20.99	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	105.31	14.90	18.88	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	95.34	4.77	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	127.49	20.16	15.42	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	140.12	19.50	17.06	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	27.05	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	140.61	17.73	12.03	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	133.13	8.28	6.21	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	124.65	6.45	4.30	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	119.75	3.99	15.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	110.20	13.78	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	126.32	6.11	8.96	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	145.38	9.53	7.94	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	125.57	11.79	5.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	144.32	6.55	7.17	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	175.10	8.02	4.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	176.22	17.74	10.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	187.46	20.54	23.11	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	175.54	16.52	13.08	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	220.19	105.89	49.98	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	157.01	61.68	35.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	189.55	95.41	48.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	222.85	151.92	81.40	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	226.78	157.00	91.58	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	219.20	149.51	65.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	127.45	47.94	29.13	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	158.16	36.15	45.19	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	150.73	59.30	22.24	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	217.67	42.07	33.73	0.99
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	197.62	41.21	19.15	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	170.11	28.52	27.50	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	112.19	13.15	3.09	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	144.82	14.41	4.96	1.89
mesothelioma cell line:ACC-MESO-4	10494-107B8	35.91	6.02	3.01	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	25.64	8.55	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	33.29	4.62	1.85	0.31
mesothelioma cell line:Mero-25	10850-111F4	9.99	0.45	0.23	0.00
mesothelioma cell line:Mero-41	10851-111F5	60.39	7.09	6.85	0.73
mesothelioma cell line:Mero-48a	10852-111F6	67.09	19.71	8.41	1.11
mesothelioma cell line:Mero-82	10853-111F7	55.19	6.04	2.89	0.26
mesothelioma cell line:Mero-83	10854-111F8	146.05	25.53	9.70	0.85
mesothelioma cell line:Mero-84	10855-111F9	43.48	2.53	2.27	0.25
mesothelioma cell line:Mero-95	10856-111G1	106.42	12.84	6.83	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	51.52	3.48	2.32	0.50
mesothelioma cell line:NCI-H226	10846-111E9	23.35	5.07	2.35	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	149.30	36.90	13.84	1.02
mesothelioma cell line:NCI-H28	10845-111E8	136.65	32.32	15.27	0.51
mesothelioma cell line:No36	10857-111G2	47.30	18.59	5.55	0.98
mesothelioma cell line:ONE58	10858-111G3	45.25	10.84	4.06	0.27
migratory langerhans cells, donor1	11901-125F2	282.13	155.65	52.01	5.18
migratory langerhans cells, donor2	11902-125F3	207.47	87.92	34.44	2.32
migratory langerhans cells, donor3	11903-125F4	310.14	88.12	40.38	1.62
mixed mullerian tumor cell line:HTMMT	10689-109F5	47.67	1.96	0.65	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	84.77	9.11	1.91	1.27
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	26.26	1.84	0.69	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	137.58	106.75	29.69	5.52
myelodysplastic syndrome cell line:SKM-1	10772-110F7	183.50	5.73	2.03	0.00
myeloma cell line:PCM6	10474-106I6	422.02	45.86	12.65	6.33
myxofibrosarcoma cell line:MFH-ino	10600-108E6	25.87	0.51	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	102.78	5.88	4.51	1.18
nasal epithelial cells, donor1, tech_rep1	12226-129F3	44.01	3.01	2.01	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	48.61	3.82	2.13	0.29
nasal epithelial cells, donor2	12227-129F4	51.89	6.07	7.18	0.55
neuroblastoma cell line:CHP-134	10508-107D4	139.19	0.23	0.92	0.00
neuroblastoma cell line:NB-1	10539-107G8	218.14	1.50	1.50	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	43.23	0.00	0.21	0.00
neuroblastoma cell line:NH-12	10555-107I6	74.35	0.19	0.37	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	34.40	0.00	1.19	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	63.99	0.63	0.00	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	63.60	1.41	0.40	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	10.17	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	52.43	8.52	2.66	0.53
neutrophil PMN, donor1	12133-128D9	44.62	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	119.53	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	94.71	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	151.87	3.38	2.20	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	122.48	1.60	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	145.23	10.26	7.05	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	137.69	32.32	16.82	0.79
nucleus accumbens, adult, pool1	10037-101F1	300.53	5.91	4.78	0.28
occipital cortex - adult, donor10196	10172-103C1	327.60	2.06	4.12	0.00
occipital cortex, adult, donor10252	10163-103B1	210.67	2.42	1.34	0.00
occipital cortex, newborn, donor10223	10355-105E4	111.73	5.46	2.55	0.36
occipital lobe, adult, donor1	10076-102A4	203.10	2.10	1.84	0.00
occipital lobe, fetal, donor1	10073-102A1	97.83	0.43	0.00	0.00
occipital pole, adult, pool1	10036-101E9	175.03	2.13	3.23	0.24
olfactory region, adult	10195-103E6	160.87	1.72	0.76	0.57
optic nerve, donor1	10277-104E7	78.04	0.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	48.41	16.17	5.81	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	73.36	5.77	1.51	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	56.22	41.15	11.34	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	36.85	1.96	1.27	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	66.73	7.94	3.23	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	50.45	0.00	1.87	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	152.47	17.60	5.30	0.00
ovary, adult, pool1	10020-101D2	135.22	2.36	0.61	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	29.88	1.47	0.18	0.55
pancreas, adult, donor1	10049-101G4	97.83	3.76	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	51.71	6.71	1.40	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	123.17	31.69	7.84	0.85
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	115.41	13.91	2.15	1.32
paracentral gyrus, adult, pool1	10035-101E8	324.17	6.68	5.40	0.09
parietal cortex, adult, donor10258	10373-105G4	188.64	4.40	2.20	0.00
parietal lobe - adult, donor10196	10171-103B9	177.75	1.88	0.94	1.88
parietal lobe, adult, donor10252	10157-103A4	203.23	2.00	2.00	0.29
parietal lobe, adult, pool1	10034-101E7	294.76	5.20	3.35	0.35
parietal lobe, fetal, donor1	10072-101I9	76.62	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	106.18	5.98	2.99	0.37
parotid gland, adult	10199-103F1	170.82	16.65	8.02	0.00
penis, adult	10200-103F2	148.78	0.54	1.61	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	20.82	0.00	0.19	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	65.42	11.22	3.35	0.73
pineal gland - adult, donor10196	10179-103C8	175.45	18.06	7.10	1.94
pineal gland, adult, donor10252	10160-103A7	744.41	27.24	20.73	2.96
pineal gland, adult, donor10258	10377-105G8	204.43	18.19	12.54	0.63
pituitary gland - adult, donor10196	10180-103C9	212.48	3.04	6.07	0.00
pituitary gland, adult, donor10252	10162-103A9	360.66	7.82	7.82	1.56
pituitary gland, adult, donor10258	10378-105G9	154.93	4.26	3.40	0.00
placenta, adult, pool1	10021-101D3	188.56	38.81	12.47	1.08
plasma cell leukemia cell line:ARH-77	10840-111E3	84.09	28.60	10.06	3.58
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	238.91	16.34	5.76	0.78
pons, adult, pool1	10033-101E6	435.07	13.94	8.35	1.20
postcentral gyrus, adult, pool1	10032-101E5	251.41	4.88	3.92	0.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	31.37	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	143.21	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	164.30	35.21	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	176.40	49.96	14.13	1.31
prostate cancer cell line:PC-3	10439-106E7	84.04	9.62	2.72	0.00
prostate, adult, pool1	10022-101D4	211.58	4.99	1.36	0.18
putamen, adult, donor10196	10176-103C5	230.40	5.43	2.12	0.24
putamen, adult, donor10252	10152-102I8	111.76	3.92	3.92	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	97.26	0.00	1.09	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	181.69	3.38	3.62	0.48
putamen, newborn, donor10223	10365-105F5	187.42	17.24	11.24	0.75
rectal cancer cell line:TT1TKB	10469-106I1	22.11	0.29	0.87	0.00
rectum, fetal, donor1	10067-101I4	50.08	2.78	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	78.02	22.47	7.00	1.06
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	120.54	20.71	3.31	2.90
retina, adult, pool1	10030-101E3	207.74	2.88	1.49	0.10
retinoblastoma cell line:Y79	10475-106I7	114.83	1.56	1.82	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	93.81	6.02	2.21	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	42.74	0.00	0.28	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	37.13	2.27	0.00	0.00
salivary acinar cells, donor1	11771-123I7	96.14	31.08	14.73	1.29
salivary acinar cells, donor2	11772-123I8	101.75	46.81	16.38	0.83
salivary acinar cells, donor3	11773-123I9	41.71	10.59	2.65	0.00
salivary gland, adult, pool1	10093-102C3	169.87	26.31	21.73	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	102.52	5.14	3.04	0.59
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	97.92	4.58	2.47	0.59
seminal vesicle, adult	10201-103F3	85.71	1.06	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	46.16	9.23	2.43	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	65.68	5.54	2.26	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	86.30	4.01	2.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	37.88	0.40	0.27	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	77.04	2.76	0.77	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	149.67	11.35	4.26	0.65
skeletal muscle - soleus muscle, donor1	10282-104F3	121.30	2.13	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	225.84	2.16	0.96	0.12
skeletal muscle, fetal, donor1	10066-101I3	70.35	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	40.71	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	145.81	1.89	3.16	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	74.71	2.67	1.67	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	54.22	0.00	0.95	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	27.37	0.96	0.39	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	60.16	0.49	0.49	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	69.81	2.09	0.80	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	49.90	0.44	0.87	0.22
small intestine, adult, pool1	10024-101D6	183.34	8.84	3.46	0.96
small intestine, fetal, donor1	10064-101I1	68.55	6.14	0.49	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	17.95	2.56	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	153.78	2.84	1.55	0.26
somatostatinoma cell line:QGP-1	10781-110G7	20.64	0.80	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	127.32	2.29	0.92	0.00
spinal cord, adult, donor10252	10159-103A6	307.14	6.31	3.55	0.79
spinal cord, adult, donor10258	10369-105F9	221.37	2.08	3.46	0.00
spinal cord, fetal, donor1	10056-101H2	139.04	3.05	3.66	1.22
spinal cord, newborn, donor10223	10359-105E8	178.17	14.24	4.13	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	71.24	6.42	2.99	0.90
spleen, adult, pool1	10025-101D7	167.18	23.35	10.02	0.99
spleen, fetal, pool1	10044-101F8	80.01	10.81	3.73	1.03
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	230.73	121.42	24.22	8.38
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	42.53	4.37	1.90	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	77.58	12.58	5.94	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	52.38	17.20	4.30	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	131.02	23.30	10.58	0.90
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	22.45	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	51.19	0.85	1.27	0.00
stomach, fetal, donor1	10062-101H8	41.65	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	137.29	15.95	4.56	1.14
substantia nigra - adult, donor10196	10178-103C7	217.10	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	336.90	2.49	1.66	0.42
substantia nigra, adult, donor10258	10371-105G2	174.31	2.07	2.59	0.00
substantia nigra, newborn, donor10223	10358-105E7	89.74	3.53	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	79.33	1.83	1.60	0.00
temporal lobe, adult, pool1	10031-101E4	167.00	3.81	3.39	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	66.95	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	68.57	2.20	0.88	0.00
tenocyte, donor1	11763-123H8	162.33	18.50	14.31	0.70
tenocyte, donor2	11765-123I1	291.85	52.65	34.72	1.14
tenocyte, donor3	11768-123I4	191.26	32.25	26.69	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	47.76	1.19	0.68	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	102.20	2.31	1.39	0.92
teratocarcinoma cell line:PA-1	10807-111A6	28.52	0.77	0.46	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	13.33	1.65	0.89	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	15.13	0.00	0.76	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	17.89	1.31	0.44	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	16.29	0.33	0.33	0.00
testis, adult, pool1	10026-101D8	177.70	3.22	2.58	0.21
testis, adult, pool2	10096-102C6	59.09	3.16	0.45	0.00
thalamus - adult, donor10196	10168-103B6	181.05	4.42	1.10	0.00
thalamus, adult, donor10252	10154-103A1	310.85	3.59	0.94	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	140.11	0.00	9.24	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	111.33	3.46	1.48	0.16
thalamus, newborn, donor10223	10366-105F6	74.22	5.18	3.45	0.58
throat, adult	10209-103G2	162.29	4.99	2.75	0.00
throat, fetal, donor1	10061-101H7	96.59	2.13	1.22	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	63.79	0.79	0.20	0.00
thymus, adult, pool1	10027-101D9	156.68	15.91	6.56	1.69
thymus, fetal, pool1	10043-101F7	162.92	18.39	7.69	1.25
thyroid carcinoma cell line:KHM-5M	10776-110G2	74.72	5.05	1.99	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	74.04	6.71	1.12	0.00
thyroid, adult, pool1	10028-101E1	225.91	4.57	2.24	0.56
thyroid, fetal, donor1	10060-101H6	61.43	1.05	0.53	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	67.75	3.08	0.00	0.00
tongue, adult	10203-103F5	142.80	3.72	1.86	0.23
tongue, fetal, donor1	10059-101H5	211.63	5.12	3.94	0.39
tonsil, adult, pool1	10047-101G2	163.09	12.82	4.51	1.40
trachea, adult, pool1	10029-101E2	149.53	16.93	6.13	0.82
trachea, fetal, donor1	10058-101H4	118.87	4.23	1.92	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	78.29	5.67	3.54	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	50.76	5.47	1.01	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	83.98	4.70	1.57	0.63
tridermal teratoma cell line:HGRT	10694-109G1	15.22	3.81	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	40.89	3.81	1.19	0.17
umbilical cord, fetal, donor1	10057-101H3	62.60	8.35	6.26	2.09
uterus, adult, pool1	10100-102D1	150.15	2.05	1.71	0.17
uterus, fetal, donor1	10055-101H1	77.30	1.54	0.00	0.00
vagina, adult	10204-103F6	91.76	3.23	1.94	0.00
vein, adult	10191-103E2	119.90	9.64	0.88	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	64.09	25.64	5.87	2.40